Molecular Partners Ag Income Statement (2020-2026) | MOLN

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
32.58M35.02M33.75M37.42M40.41M40.98M40.56M46.08M48.77M50.52M
Revenue & cost
Revenue (Quarter)
-1071.42M0.00M10.57M0.19M12.21M2,447.82M155.51M3,297.55M0.46M0.00M7.93M3,136.88M1.72786.02-5667.66M0.02M0.02M0.02M-0.06M0.02M
Operating items
Research & Development (Quarter)
-34.65M-0.01M60.47M0.02M-13.05M-0.01M52.72M-0.01M-12.94M-0.01M55.04M-0.02M-0.01M-0.01M55.53M-0.01M-0.01M-0.01M50.33M-0.01M
Selling, General & Administrative (Quarter)
-8.37M-0.01M18.94M0.01M-5.69M-0.01M23.10M-0.01M-5.19M-0.01M21.84M-0.01M-0.00M-0.01M20.09M-0.00M-0.00M-0.00M19.08M-0.01M
Restructuring Costs (Quarter)
-0.00M-145.01-3.37M
Other Operating Expenses (Quarter)
-20.08M1.25-116.28M
Operating Expenses (Quarter)
-43.02M-0.02M79.42M0.02M-18.74M-0.02M75.82M-0.02M-18.13M-0.02M76.88M-0.02M-0.02M-0.02M55.54M-0.02M-0.02M-0.02M-50.24M-0.02M
Operating Income (Quarter)
158.39M-17.66M-17.67M-20.92M
EBIT (Quarter)
-37.14M-0.01M-68.52M0.17M158.39M-0.01M128.36M-0.02M-17.66M-0.01M-66.26M-0.01M-17.67M-0.02M-62.16M-0.02M-20.92M-0.01M-75.53M-0.02M
Non-operating items
Interest & Investment Income (Quarter)
1.69M717.740.20M891.152.09M0.00M1.93M937.371.21M0.00M4.82M0.01M0.00M828.728.21M558.35507.31457.54-4.38M395.87
Other Non Operating Income (Quarter)
-0.59M-2.91M-1.25M-0.19M
Non Operating Income (Quarter)
1.84M0.34M5.01M-3.72M
Net income details
EBT (Quarter)
-36.79M-0.01M-69.12M0.17M-4.70M-0.01M127.71M-0.02M-17.78M-0.01M-72.07M-0.01M-0.02M-0.02M-62.21M-0.02M-0.02M-0.01M-81.84M-0.02M
Tax Provisions (Quarter)
5.550.00M6.28-6.026.01-6.026.166.45-12.856.536.580.00M2.226.767.000.00M7.15
Profit After Tax (Quarter)
-36.79M-0.01M-69.13M0.17M-4.70M-0.02M122.19M-0.02M-17.78M-0.01M-69.83M-0.01M-0.02M-0.02M67.63M-0.02M-0.03M-0.02M-77.14M-0.02M
Income from Non-Controlling Interests (Quarter)
7.16M0.00M0.00M4.53M-0.00M28.11-1.71M756.280.00M0.00M-0.00M0.00M-0.00M-462.54346.07
Income from Continuing Operations (Quarter)
-36.79M-0.01M-69.13M0.17M-4.70M-0.01M127.71M-0.02M-17.78M-0.01M-72.07M-0.01M-0.02M-0.02M-62.21M-0.02M-0.02M-0.01M-81.84M-0.02M
Consolidated Net Income (Quarter)
-36.79M-0.01M-69.13M0.17M-4.70M-0.01M127.71M-0.02M-17.78M-0.01M-72.07M-0.01M-0.02M-0.02M-62.21M-0.02M-0.02M-0.01M-81.84M-0.02M
Income towards Parent Company (Quarter)
-36.79M-0.01M-69.13M0.17M-4.70M-0.01M127.71M-0.02M-17.78M-0.01M-72.07M-0.01M-0.02M-0.02M-62.21M-0.02M-0.02M-0.01M-81.84M-0.02M
Net Income towards Common Stockholders (Quarter)
-36.79M-0.01M-69.13M0.17M-4.70M-0.01M127.71M-0.02M-17.78M-0.01M-72.07M-0.01M-0.02M-0.02M-62.21M-0.02M-0.02M-0.01M-81.84M-0.02M
Additional items
EPS (Basic) (Quarter)
-1.240.00-2.230.01-0.140.003.930.00-0.540.00-2.200.000.000.00-1.830.000.000.00-2.200.00
EPS (Diluted) (Quarter)
-1.240.00-2.230.01-0.140.003.840.00-0.540.00-2.200.000.000.00-1.830.000.000.00-2.200.00
Shares Outstanding (Quarter)
29.71M29.71M31.01M31.01M32.50M32.50M32.47M32.47M32.83M32.83M32.77M32.77M33.18M33.18M34.03M34.03M37.39M37.39M37.27M37.27M
Shares Outstanding (Diluted) (Quarter)
29.71M29.71M31.01M31.01M32.50M32.50M33.27M33.27M32.83M32.83M32.77M32.77M33.18M33.18M34.03M34.03M37.39M37.39M37.27M37.27M
EBITDA (Quarter)
-37.14M-0.01M-68.52M0.17M158.39M-0.01M128.36M-0.02M-17.66M-0.01M-66.26M-0.01M-17.67M-0.02M-62.16M-0.02M-20.92M-0.01M-75.53M-0.02M
Interest Expenses (Quarter)
-0.35M-142.680.60M269.62-0.25M-121.150.64M-602.21-1.33M-12.455.81M-11.460.02M-0.00M0.04M-0.00M4.23M-196.276.31M-14.05
Tax Rate (Quarter)
-0.040.000.000.00-0.040.00-0.04-0.050.00-0.05-0.030.00-0.01-0.03-0.050.00-0.04